Nature Publishing Group
British Journal of Cancer
Life Sciences and Health

Schramm, A, Schowe, B, Fielitz, K, Heilmann, M, Martin, M, Marschall, T, … Schulte, J.H. (2012). Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome. British Journal of Cancer, 107, 1409–1417.